JBMR Plus, Vol 3, Iss 11, Pp n/a-n/a (2019) JBMR Plus, 3(11):e10230. Wiley-Blackwell Publishing Ltd Repisalud Instituto de Salud Carlos III (ISCIII) Sánchez-Duffhues, G, Williams, E, Benderitter, P, Orlova, V, van Wijhe, M, Garcia deVinuesa, A, Kerr, G, Caradec, J, Lodder, K, de Boer, H C, Goumans, M-J, Eekhoff, E M W, Morales-Piga, A, Bachiller-Corral, J, Koolwijk, P, Bullock, A N, Hoflack, J & Ten Dijke, P 2019, ' Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells ', JBMR Plus, vol. 3, no. 11, e10230 . https://doi.org/10.1002/jbm4.10230 JBMR Plus
Renal Failure Thomsen, L H, Fog-Tonnesen, M, Nielsen Fink, L, Norlin, J, GarcíadeVinuesa, A, Hansen, T K, de Heer, E, Ten Dijke, P & Rosendahl, A 2017, ' Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model ', Renal Failure, vol. 39, no. 1, pp. 629-642 . https://doi.org/10.1080/0886022X.2017.1361837 Renal Failure, 39(1), 629-642